EL7.AI
StocksMedium•19 November 2026•
3 min read

UnitedHealth Shares Fall 10.21% as Insurers Face Pressure and Medicare Advantage Audit Proposal

Key Facts

1UnitedHealth shares closed at $349.91, down 10.21% on November 18, 2026.
2CMS estimates federal budget savings of about $90 billion and costs of about $378.51 million during 2027–2036.
3CMS estimates that the proposed changes to Medicare Advantage audits could allow it to collect an average of nearly $9 billion for each payment year.
4CMS set January 19, 2027, as the deadline for public comments on the proposal.

UnitedHealth Group shares fell 10.21% to close at $349.91 in the November 18, 2026 session, recording a 10% loss during the session, according to Dow Jones coverage via MarketScreener. The decline came amid a wave of pressure on health insurers as investors assessed a federal proposal to expand Medicare Advantage audits. The coverage also linked the move to renewed calls for Medicare for All, so it did not attribute the drop solely to the regulatory proposal. In the two days before the session, the Centers for Medicare & Medicaid Services, known as CMS, issued a separate proposal to strengthen oversight of the integrity of healthcare programs. This puts the stock's losses in the context of a broader debate about auditing government payments and health insurance policies.

CMS issued the CRUSH proposal on November 16, 2026, to combat fraud, waste and abuse in Medicare, Medicaid, the Children's Health Insurance Program (CHIP) and the health insurance marketplace. The proposal includes changes to provider enrollment, oversight of Medicare Advantage and Part D, Medicaid and CHIP programs, requirements for medical equipment suppliers, and the insurance marketplace. The agency says the quantitative measures in the proposal could generate nearly $90 billion in federal budget savings, against estimated costs of about $378.51 million during 2027–2036. These are CMS estimates for the proposal at the federal budget level and are not a published estimate of UnitedHealth's costs or its impact on the company's margins. CRUSH remains a proposal; its issuance does not mean its provisions have become a final, effective rule.

In 2025 data reviewed by CMS, 46% of Medicare Part C and Part D contracts voluntarily reported confirmed or suspected fraud referrals. Nineteen percent of those contracts reported suspending payments over credible fraud allegations. The text proposes making fraud-referral reporting mandatory and expanding it to include payment suspensions across different providers and suppliers. These percentages are based on the agency's review of the two programs' contracts during calendar year 2025, while the proposal sets broader reporting and oversight rules. For managed care in Medicaid, CMS proposes requiring plans to report a beneficiary's death or change of address within 30 days, and to return overpayments associated with people who have died or moved out of state.

For Medicare Advantage, CMS proposes not applying the fee-for-service adjuster in risk-adjustment audits and beginning to extrapolate the results of audits for payment year 2018. The agency estimates that this approach could allow it to collect an average of nearly $9 billion in overpayments for each payment year. This provision is tied to expanding the impact of audit findings, as CMS proposes using extrapolation starting with audits for payment year 2018. The estimated annual collection puts payment audits at the center of the financial impact the agency expects from changes to Medicare Advantage. However, the figure remains a CMS estimate under a proposed rule, not an amount already collected.

Wednesday's decline cut into UnitedHealth's gains since the start of the year, which narrowed to 4% after the session's loss, according to Dow Jones coverage. Trading data on the morning of November 18 had shown the stock down 4.2% at $373.47, according to an Investing.com report, before it closed at $349.91. CMS set January 19, 2027, as the deadline for public comments on the CRUSH proposal. The text also proposes that the requirement for eligible providers and suppliers billing Medicare Advantage plans under Original Medicare to have approved status begin, with PACE plans exempt. If adopted, this requirement would take effect on the first day of the plan year that falls two years after publication of the final rule.

Open on chart